Sulfuric Acid → HCID 58930409, compound
Reaction equation
C[N:2]1[CH2:7][CH2:6][CH:5]([CH2:8][CH2:9]CCOC2C=C(C=CC=2)C=O)[CH2:4][CH2:3]1.[CH3:21][N:22]1[CH2:27][CH2:26][CH:25]([CH2:28][CH2:29][CH2:30][CH2:31][O:32][C:33]2[CH:34]=[C:35]([CH:38]=[CH:39][CH:40]=2)[C:36]#[N:37])[CH2:24][CH2:23]1.[CH3:41]C(C[AlH]CC(C)C)C.OS(O)(=O)=O.[OH-].[Na+].C(C(C(C([O-])=O)O)O)([O-])=O.[K+].[Na+].[CH2:69]([Cl:71])Cl>C1(C)C=CC=CC=1.CO>[Cl:71][C:69]1[CH:3]=[CH:4][C:5]([C:6]2[N:37]=[C:36]([C:35]3[CH:34]=[C:33]([CH:40]=[CH:39][CH:38]=3)[O:32][CH2:31][CH2:30][CH2:29][CH2:28][CH:25]3[CH2:24][CH2:23][N:22]([CH3:21])[CH2:27][CH2:26]3)[NH:2][C:7]=2[CH3:41])=[CH:8][CH:9]=1Participants
Reactant 7
Product 1
Reagents, catalysts & solvents 2
Procedure
3-[4-(1-Methyl-piperidin-4-yl)-butoxy]-benzonitrile. To a 0° C. solution of 4-(1-methyl-piperidin-4-yl)-butan-1-ol (0.74 g, 4.37 mmol), 3-hydroxy-benzonitrile (0.52 g, 4.37 mmol), and 3 mmol/g polymer supported PPh3 (2.30 g, 8.73 mmol) in THF (40 mL) was added diisopropyl azodicarboxylate (1.72 mL, 8.73 mmol) dropwise. After 6 h the mixture was filtered and concentrated. Purification by Method 1 afforded 840 mg (71%) of a yellow oil. MS (ESI): mass calcd for C17H24N2O, 272.19. m/z found, 273.4 [M+H]+. 1H NMR (400 MHz, CDCl3): 7.38-7.33 (m, 1H), 7.24-7.20 (m, 1H), 7.14-7.09 (m, 2H), 3.96 (t, J=6.4, 2H), 2.88-2.80 (m, 2H), 2.26 (s, 3H), 1.94-1.84 (m, 2H), 1.82-1.73 (m, 2H), 1.72-1.64 (m, 2H), 1.52-1.42 (m, 2H), 1.34-1.17 (m, 5H). B. 3-[4-(1-Methyl-piperidin-4-yl)-butoxy]-benzaldehyde. To a stirred solution of 3-[4-(1-methyl-piperidin-4-yl)butoxy]-benzonitrile (0.84 g, 3.09 mmol) in toluene (5 mL) at 0° C. was added 1.5 M DIBAL-H in toluene (4.63 mL, 4.63 mmol). After 3 h, methanol (9 mL) and 1.0 M H2SO4 (10 mL) were added dropwise. After stirring for 30 min, the solution was neutralized with 1.0 M sodium hydroxide (10 mL) followed by addition of satd. aq. sodium potassium tartrate (40 mL) and CH2Cl2 (100 mL). After stirring for 30 min the solution was extracted with CHCl3 (3×50 mL), washed with brine and dried over Na2SO4. Purification by Method 1 afforded 0.56 g (66%) of the title compound. 1H NMR (400 MHz, CDCl3): 9.97 (s, 1H), 7.46-7.43 (m, 2H), 7.39-7.37 (m, 1H), 7.19-7.15 (m, 1H), 4.02 (t, J=6.6, 2H), 2.86-2.80 (m, 2H), 2.25 (s, 3H), 1.92-1.83 (m, 2H), 1.83-1.75 (m, 2H), 1.73-1.63 (m, 2H), 1.54-1.44 (m, 2H), 1.34-1.18 (m, 5H). C. 4-(4-{3-[4-(4-Chloro-phenyl)-5-methyl-1H-imidazol-2-yl]-phenoxy}-butyl)-1-methyl-piperidine. Preparation using the method described in General Procedure 3 afforded 49 mg (28%) of the title compound. MS (ESI): mass calcd for C26H32ClN3O, 437.22. m/z found, 438.4 [M+H]+. 1H NMR (400 MHz, CDCl3): 10.2 (br s, 1H), 7.64 (br s, 1H), 7.48-7.44 (m, 1H), 7.41-7.26 (m, 4H), 7.31-7.27 (m, 1H), 6.88-6.84 (m, 1H), 3.95-3.85 (m, 2H), 2.85-2.77 (m, 2H), 2.43 (s, 3H), 2.25 (s, 3H), 1.93-1.82 (m, 2H), 1.76-1.60 (m, 4H), 1.45-1.35 (m, 2H), 1.30-1.15 (m, 5H).
Workup
- additionfollowed by addition of satd
- stirringAfter stirring for 30 min the solution
- extractionwas extracted with CHCl3 (3×50 mL)
- washwashed with brine
- dry with materialdried over Na2SO4
- customPurification by Method 1
Sources & evidence
- ORD record
- ord-59651dc142364b288eeb846d172af161
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08017639B2
Reaction notes
Loading…